S&P Futures
4,026.25 -9.50 (-0.24%) Dow Futures
32,712.00 -62.00 (-0.19%) Nasdaq Futures
12,816.00 -51.25 (-0.40%) Russell 2000 Futures
1,790.40 -2.90 (-0.16%) Crude Oil
69.16 -0.51 (-0.73%) Gold
1,946.70 +5.60 (+0.29%)
Pressure BioSciences, Inc. (PBIO)
Chart Events
Performance Outlook
| Previous Close | 1.3500 |
| Open | 1.3500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.3250 - 1.4500 |
| 52 Week Range | 0.9100 - 2.4000 |
| Volume | |
| Avg. Volume | 22,418 |
| Market Cap | 16.987M |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.6300 |
| Earnings Date | Nov 22, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PBIO
Related Research
- PRESSURE BIOSCIENCES INCMarket Digest: LVS, MRK, NSC, GNRC, DOCUStocks held up on March 13 after some ugly early action that saw the S&P 500 (SPX) down about 1.3%. The index rallied almost 100 points by late morning before selling off over the balance of the day. It was a great session for day traders, but created more agita for the rest of us. The morning low coincided with chart support in the 3,780-3,810 region from the late-December low. On March 14, gains were solid and broad-based.RatingFair ValueEconomic Moat7 days agoArgus Research
- GlobeNewswire
Presenting on the Emerging Growth Conference on March 22 Register Now
MIAMI, March 21, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 52nd Emerging Growth Conference on March 22, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting companies
- ACCESSWIRE
Pressure BioSciences Announces the Exchange of Over $10 Million of Debt into Equity
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, today announced that the Company's largest shareholder has exchanged over $10 million of senior secured debt into unsecured preferred stock.
- News Direct
Pressure BioSciences’ Breakthrough UltraShear Nanoemulsion Processing Could Help Revolutionize The Edible Cannabis Industry
By Rachael Green, Benzinga
